Le marché de l'édition du génome devrait passer de 5,19 milliards de dollars américains en 2021 à 16,98 milliards de dollars américains d'ici 2028 ; on estime qu'il augmentera à un TCAC de 18,4 % entre 2021 et 2028.
Les technologies d'édition du génome permettent aux scientifiques de modifier l'ADN, entraînant des changements dans les traits physiques, comme la couleur des yeux et la maladie risque. Les scientifiques utilisent différentes technologies pour ce faire. Ces technologies agissent comme des ciseaux, coupant l'ADN à un endroit précis. Ensuite, les scientifiques peuvent retirer, ajouter ou remplacer l'ADN là où il a été coupé. CRISPR est plus simple, plus rapide, moins cher et plus précis que les anciennes méthodes d'édition du génome. De nombreux scientifiques qui effectuent l'édition du génome utilisent désormais CRISPR.
Insights stratégiques
Les facteurs qui stimulent la croissance du marché mondial de l'édition du génome sont les augmentation de la prévalence du cancer, augmentation du taux de maladies génétiques et croissance rapide des initiatives de recherche et de développement autour des outils et des techniques d'édition de gènes.
Régions lucratives sur le marché de l'édition du génome
Perspectives du marché Progrès technologiques continus dans les outils d'édition de gènes
Au cours des dernières années, les avancées dans les technologies d'édition du génome ont constamment fait la une des journaux. Les technologies d'édition du génome peuvent modifier la recherche biologique et avoir un impact significatif sur la santé humaine, la sécurité alimentaire et la durabilité environnementale, car elles sont précises, relativement peu coûteuses, faciles à utiliser et remarquablement puissantes. Les progrès de l'édition du génome remontent à des débuts tranquilles dans les années 1990. L'introduction de CRISPR-Cas9, un outil d'édition du génome qui peut être utilisé pour effectuer facilement des modifications précises et ciblées de la séquence d'ADN, est principalement responsable de l'augmentation récente du nombre et de la portée des applications des technologies d'édition du génome. Par exemple, en octobre 2020, les résultats d'une étude sur boîte de Pétri ont révélé que CRISPR/Cas9 peut potentiellement être utilisé pour modifier un gène particulier dans les cellules nerveuses du cerveau humain, ralentissant ainsi la production de la protéine bêta-amyloïde, qui est responsable pour déclencher la maladie d'Alzheimer.
Reconnaissant le potentiel des techniques d'édition du génome pour étudier et manipuler le génome, le Département de biotechnologie (DBT) encourage la recherche et l'innovation dans les technologies d'ingénierie du génome et des applications pour les rendre plus accessibles et peu coûteuses pour la recherche et le développement. Cela a permis d'identifier plusieurs nouveaux régulateurs de l'homéostasie cellulaire, ainsi que de multiples cibles thérapeutiques potentielles pour les maladies de surcharge lysosomale. Ces facteurs pour la recherche sur le système CRISPR sont susceptibles de favoriser la croissance du marché.
Technology-Based Insights
Le marché de l'édition du génome, en technologie, est segmentée en CRISPR, TALEN, antisens et autres. Le segment CRISPR détenait la plus grande part du marché en 2021 et devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision. La croissance du marché pour ce segment est attribuée à l'utilisation actuelle de CRISPR, à la consommation élevée de volumes et à l'innovation des produits.
Marché de l'édition du génome, par technologie - 2021 et 2028
Insights basés sur les applications
Par application, le marché de l'édition du génome est segmenté en ingénierie de lignées cellulaires, génie génétique, applications de diagnostic, découverte de médicaments et autres. En 2021, le segment de l'ingénierie des lignées cellulaires détenait la plus grande part du marché. De plus, le segment devrait enregistrer le TCAC le plus élevé de 2021 à 2028, en raison de l'augmentation de la détection et du diagnostic de diverses conditions médicales à travers le monde.
Basé sur l'utilisateur final Insights
Le marché de l'édition du génome, par les utilisateurs finaux, est segmenté en sociétés pharmaceutiques et biotechnologiques, instituts universitaires et de recherche et organismes de recherche clinique (CRO). En 2021, le segment des sociétés pharmaceutiques et biotechnologiques détient la plus grande part du marché. De plus, le segment devrait enregistrer le TCAC le plus élevé de 2021 à 2028, en raison de l'augmentation de la détection et du diagnostic de diverses conditions médicales à travers le monde
Les lancements et approbations de produits sont stratégies couramment adoptées par les entreprises pour étendre leur empreinte mondiale et leurs portefeuilles de produits. De plus, les acteurs du marché de l'édition du génome se concentrent sur la stratégie de partenariat pour élargir leur clientèle, ce qui, à son tour, leur permet de maintenir leur marque à l'échelle mondiale.
Profils des entreprises
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Lonza
- Horizon Discovery Group plc.
- Technologies ADN intégrées
- GenScript
- New England Biolabs
- Eurofins Scientific
- CRISPR Therapeutics
- Editas Medicine
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global genome editing market based on technology, is segmented into CRISPR, TALEN, Antisense, and others. The CRISPR segment held the largest share of the market in 2021 and register the highest CAGR during the forecast period.
The factors that are driving and restraining factors that will affect the genome editing market in the coming years. Factors such as the rising prevalence of cancer, the growing rate of genetic disorders. However, the high cost of genomics hampers the genome editing market.
The genome editing market majorly consists of the players such as Thermo Fisher Scientific Inc.; Merck KGaA; Lonza; Horizon Discovery Group plc.; Integrated DNA Technologies; GenScript; New England Biolabs; Eurofins Scientific; CRISPR Therapeutics; Editas Medicine amongst others.
Genome editing technologies enable scientists to change DNA, leading to changes in physical traits, like eye color and disease risk. Scientists use different technologies to do this. These technologies act like scissors, cutting the DNA at a specific spot. Then scientists can remove, add, or replace the DNA where it was cut. CRISPR is simpler, faster, cheaper, and more accurate than older genome editing methods. Many scientists who perform genome editing now use CRISPR.
The List of Companies - Genome Editing Market
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGaA
- Lonza
- Horizon Discovery Group plc.
- Integrated DNA Technologies
- GenScript
- New England Biolabs
- Eurofins Scientific
- CRISPR Therapeutics
- Editas Medicine
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jan 2022
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2022
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2022
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2022
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jan 2022
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jan 2022
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jan 2022
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)